Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The Company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases.
|Wellington Partners, Ventech, Farallon Capital Management, Omnes Capital, Credit Agricole CIB, aws Gründerfonds (aws Founders Fund), Global Health Investment Fund (GHIF), Merck, Hadean Ventures, Adjuvant Capital|
When was Themis Bioscience founded?
Themis Bioscience was founded in 2009.
Who are Themis Bioscience key executives?
Themis Bioscience's key executives are Erich Tauber, Philippe Dro and Lee Smith.
How many employees does Themis Bioscience have?
Themis Bioscience has 36 employees.
Who are Themis Bioscience competitors?
Competitors of Themis Bioscience include Xenotherapeutics Inc, Cell Genesys and Yumanity Therapeutics.
Where is Themis Bioscience headquarters?
Themis Bioscience headquarters is located at 11/2 Muthgasse, Wien.
Where are Themis Bioscience offices?
Themis Bioscience has an office in Wien.
How many offices does Themis Bioscience have?
Themis Bioscience has 1 office.
Receive alerts for 300+ data fields across thousands of companies